Pseudoephedrine hydrochloride 120 mg Tablet, Film Coated, 10-count — NDC 70677-1019-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Pseudoephedrine hydrochloride 120 mg Tablet, Film Coated, 10-count — NDC 70677-1019-1 (Billing 70677-1019-01)

by STRATEGIC SOURCING SERVICES LLC · 1 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK

This is a package of 10 tablets of Pseudoephedrine hydrochloride 120 mg Tablet, Film Coated from STRATEGIC SOURCING SERVICES LLC, first listed with the FDA Aug 2023 and currently FDA-listed; retail pharmacies pay about $0.2947 per tablet (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 70677-1019-01
🏷️ FDA NDC (as labeled) 70677-1019-1 billing pads the package segment with a zero
This package
Contains10-count Cost per ea$0.2947 NADAC Per package$2.95 / 10 tablets Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.6172/unit — full pricing hub ↓
Main listing for product 70677-1019 · Also comes in: 10 tablets 70677-1019-2
OTC Generic FDA-listed Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Nov 19, 2026 · this listing last changed Nov 12, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 70677-1019-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70677 labeler · 1019 product · 1 package
Package marketed since
Aug 10, 2023
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
10 EA per package
Barcode (UPC)
0010939955371
Medicaid fills, this package
87 prescriptions in the last four reported quarters
FDA record last changed
Nov 12, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1019-1
Product NDC 70677-1019
11-digit billing NDC 70677101901
NCPDP billing unit EA — each (per item)
RxCUI 1049154
UNII 6V9V2RYJ8N
UPC 0010939955371
Application # ANDA077442
SPL Set ID 3bf95c58-4fd9-4caa-a54f-2e61a5eacae8
Established class (EPC) alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status FDA-listed
FDA listing status Listed (active directory)
Marketing start 2023-08-10
Route ORAL
Dosage form TABLET, FILM COATED
Substance PSEUDOEPHEDRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 016937
GCN 26901
HICL code 002091
Ingredient (HICL) Pseudoephedrine Hcl
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B6
Therapeutic class — intermediate (HIC2) Drugs Affecting The Trachea And Bronchi (Cont3)
HIC3 code B6V
Therapeutic class — specific (HIC3) Decongestants, Oral
AHFS code 12:12.12.00
AHFS class Alpha- And Beta-Adrenergic Agonists
FDB label name FT NASAL DECONGEST ER 120 MG
FDB brand name Nasal Decongestant
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 016937
  • GCN: 26901
  • HICL (First Databank): 002091
  • AHFS class code: 12:12.12.00
  • RxCUI (RxNorm): 1049154
Why two NDCs? The FDA registers this code as 70677-1019-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1019-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the alpha-Adrenergic Agonist class.

Pharmacologic class alpha-Adrenergic Agonist
Drug family (ATC) Sympathomimetics
How it works Adrenergic alpha-Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT NASAL DECONGEST ER 120 MG Ingredient Pseudoephedrine Hcl
📖 What it is MedlinePlus · NLM

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Most products also relieve sinus congestion and pressure. It treats s...
  • It depends on the product. Regular tablets and softgels are repeated every 4 to 6 hours, 12-hour tablets about every 12 hours, and a 24-hour tablet once a day. Check your label for...
  • No. Swallow them whole with water and don't divide, crush, chew or dissolve them. You may see the tablet in your stool, and the label says that's normal.
  • Can I crush or chew extended-release pseudoephedrine tablets?
📖 Read our full Pseudoephedrine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.295 $2.95 / 10 tablets
Medicaid paysCMS SDUD · 12 mo $0.6172 $6.17 / 10 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2024 Jul 2025 Mar 2026 Nov 2026 $0.295 $0.262
▲ Up 3% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
70677-1019-01 You're viewing this Main listing 1 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK $0.2947 / ea $2.95 2023-08-10 — Active
70677-1019-02 70677-1019-2 2 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK $0.2947 / ea $5.89 2026-05-06 — Active

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.2947 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 10-count package — 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack.
What NDC number is used to bill for this package of Pseudoephedrine hydrochloride 120 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pseudoephedrine Hydrochloride 120 mg 62011-0306-01 STRATEGIC 10 tablets $0.276 — Discontinued save 6%
leader 12 hour nasal decongestant 120 mg 70000-0475-01 Cardinal 1 tablet $0.276 — FDA listed save 6%
nasal decongestant 120 mg 70677-0001-01 Strategic 10 tablets $0.285 — Discontinued save 3%
Good Sense Suphedrine 12 Hour 120 mg 00113-0054-52 L. 1 tablet $0.295 — Availability likely —
sinus 12 hour 120 mg 00113-2017-60 L. 1 tablet $0.295 — Availability likely —
SudoGest 12 Hour 120 mg 00904-6754-15 Major 1 tablet $0.295 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 00904-7409-15 Major 10 tablets $0.295 — Availability likely —
good neighbor pharmacy nasal decongestant 120 mg 24385-0054-52 Amerisource 1 tablet $0.295 — Availability likely —
pseudoephedrine hydrochloride 120 mg 45802-0107-52 Padagis 1 tablet $0.295 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 51660-0204-21 Ohm 20 tablets $0.295 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 51660-0492-21 Ohm 20 tablets $0.295 — Availability likely —
Pseudoephedrine Hydrochloride 120 mg 70000-0601-01 CARDINAL 20 tablets $0.295 — Availability likely —
12 Hour Nasal Decongestant 120 mg 70000-0656-01 CARDINAL 10 tablets $0.295 — Availability likely —
Pseudoephedrine hydrochloride 120 mgthis 70677-1019-01 STRATEGIC 10 tablets $0.295 — Availability likely —
Nasal Decongestant D 120 mg 00363-3301-52 Walgreen 1 tablet — — FDA listed —
sinus pressure and congestion relief maximum strength 120 mg 11822-0650-06 Rite 1 tablet — — FDA listed —
Pseudoephedrine HCl 120 mg 21130-0158-67 Better 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 21130-0204-21 Safeway 20 tablets — — Discontinued —
Pseudoephedrine hydrochloride 120 mg 30142-0967-20 The 20 tablets — — FDA listed —
topcare 12 hour decongestant 120 mg 36800-0054-52 Topco 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 37808-0007-69 HEB 20 tablets — — FDA listed —
Equaline 12 Hour Decongestant 120 mg 41163-0054-60 United 1 tablet — — FDA listed —
nasal decongestant 120 mg 41250-0809-52 Meijer 1 tablet — — FDA listed —
CareOne Nasal and Sinus Decongestant 120 mg 41520-0429-52 American 1 tablet — — FDA listed —
equate sinus 12 hour 120 mg 49035-0508-60 Wal-Mart 1 tablet — — FDA listed —
Sudafed Sinus Congestion 12 Hour 120 mg 50090-4629-00 A-S 10 tablets — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 50090-5554-00 A-S 10 tablets — — FDA listed —
Sudafed Sinus Congestion 12 Hour 120 mg 50580-0242-01 Kenvue 10 tablets — — FDA listed —
sinus and nasal decongestant 120 mg 51316-0616-52 CVS 1 tablet — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 53943-0204-10 DISCOUNT 10 tablets — — Discontinued —
nasal decongestant 120 mg 56062-0054-60 Publix 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 56062-0204-21 Publix 20 tablets — — FDA listed —
Pseudoephedrine HCl 120 mg 58602-0804-67 Aurohealth 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 59779-0204-21 CVS 20 tablets — — Discontinued —
12 Hour Nasal Decongestant 120 mg 59779-0703-52 CVS 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 63868-0143-10 Chain 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 68016-0204-69 Chain 10 tablets — — Discontinued —
Pseudoephedrine hydrochloride 120 mg 68196-0204-20 SAM'S 10 tablets — — FDA listed —
Leader 12 Hour Sinus Nasal Decongestant 120 mg 70000-0735-01 Cardinal 1 tablet — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 85766-0050-10 Sportpharm 10 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
Listed with the FDA since
Aug 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
This is a generic
listed with the FDA
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeCapsule
Imprint204
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Pseudoephedrine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D5340Y2I9G
    Castor oil is a natural plant-based oil used in medicines as a lubricant, laxative agent, and solvent. It helps medicine ingredients dissolve or flow smoothly and can aid bowel movement in formulations designed for that purpose.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescastor oil, colloidal silicon dioxide, hypromellose, microcrystalline cellulose, magnesium stearate, titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSTRATEGIC SOURCING SERVICES LLC
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA077442 (ANDA)
Labeler code70677
First marketedAug 2023
Product typeHuman Otc Drug
Portfolio318 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 23 words ▾

Uses temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure

⏱️ Dosage and Administration 40 words ▾

Directions adults and children 12 years and over take 1 tablet every 12 hours do not take more than 2 tablets in 24 hours children under 12 years do not use this product in children under 12 years of age

⚠️ Warnings 145 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland When using this product do not exceed recommended dosage Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur symptoms do not improve within 7 days or occur with a fever If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📦 Storage and Handling 32 words ▾

Other information store at 59° to 77° F in a dry place. Protect from light TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.

🧪 Active Ingredient 10 words ▾

Active ingredient (in each tablet) Pseudoephedrine HCl, USP 120 mg

🧪 Inactive Ingredients 14 words ▾

Inactive ingredients castor oil, colloidal silicon dioxide, hypromellose, microcrystalline cellulose, magnesium stearate, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Nasal decongestant

📄 Do Not Use 55 words ▾

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 24 words ▾

Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland

📄 When Using This Product 9 words ▾

When using this product do not exceed recommended dosage

📄 Stop Use and Ask a Doctor If 24 words ▾

Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur symptoms do not improve within 7 days or occur with a fever

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📄 Questions or Comments 10 words ▾

Questions? Call 833-358-6431 M - F, 9AM - 7PM EST

📄 Package Label / Principal Display Panel 57 words ▾

PRINCIPAL DISPLAY PANEL - 120 mg Tablet Blister Pack Carton NDC 70677-1019-1 COMPARE TO SUDAFED ® SINUS CONGESTION 12 HOUR ACTIVE INGREDIENT* Foster & Thrive ® MAXIMUM STRENGTH Nasal Decongestant Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, USP Long-Acting Nasal Decongestant Non-Drowsy 12 hour Sinus Pressure + Congestion ACTUAL SIZE 10 Coated Capsule-Shaped Tablets 120 mg Each Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
87
Units reimbursed last 4 qtrs
2.3K
Gross reimbursed last 4 qtrs
$1.4K
Avg / prescription
$16.58
Avg / unit
$0.6172
Latest quarter Q1 2026
28Rx
Medicaid pays / ea
$0.6172
gross reimbursed
vs
NADAC / ea
$0.2947
acquisition cost
=
Spread
+$0.3225
+109% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 87 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 452 units · 22.9 per 100k residents NE Missouri: no data reported MO Kentucky: 1,885 units · 41.6 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
22.941.6
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 41.6 /100k
2 Nebraska 22.9 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 213 Rx · 5,648 units · $2,790 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Pseudoephedrine Hydrochloride — the ingredient across all brands.

Top reported reactions

Pain6,379
Fatigue6,340
Abdominal Discomfort5,499
Systemic Lupus Erythematosus5,387
Rheumatoid Arthritis5,340
Rash5,334
Pemphigus5,231

Age at onset

Neonate80
Infant8
Child110
Adolescent82
Adult3,991
Elderly1,962

Reporter sex

36,729 reports
Male · 27%
Female · 73%
Unknown · 0%

Serious outcomes

Hospitalization9,866
Disabling5,402
Death5,177
Life-threatening4,457
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 3,614 1,530
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.